MLchartDataset catalogue

triacetyluridine

Term · Oncology and biomedicine · MLC-T-ONC-008893

A drug used in the emergency treatment of adults and children who receive too much fluorouracil or capecitabine or who have heart or central nervous system toxicity or other serious side effects that occur within 4 days of ending treatment with these drugs. Triacetyluridine may help protect healthy cells from some of the side effects caused by certain anticancer drugs. It is a type of chemoprotective agent and a type of pyrimidine analog. Also called PN401, uridine triacetate, and Vistogard.

Table 1. Record
IdentifierMLC-T-ONC-008893
FieldOncology and biomedicine
SynonymsPN401; uridine triacetate; Vistogard
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008893",
  "term": "triacetyluridine",
  "field": "Oncology and biomedicine",
  "definition": "A drug used in the emergency treatment of adults and children who receive too much fluorouracil or capecitabine or who have heart or central nervous system toxicity or other serious side effects that occur within 4 days of ending treatment with these drugs. Triacetyluridine may help protect healthy cells from some of the side effects caused by certain anticancer drugs. It is a type of chemoprotective agent and a type of pyrimidine analog. Also called PN401, uridine triacetate, and Vistogard.",
  "synonyms": [
    "PN401",
    "uridine triacetate",
    "Vistogard"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/triacetyluridine/"
}

Record 16,696 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.